EMAM
Encompass More Asset Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264K | Sell |
3,824
-340
| -8% | -$23.5K | 0.06% | 173 |
|
|
2025
Q1 | $289K | Buy |
4,164
+767
| +23% | +$53.3K | 0.09% | 154 |
|
|
2024
Q4 | $292K | Buy |
3,397
+1,128
| +50% | +$97K | 0.1% | 151 |
|
|
2024
Q3 | $270K | Buy |
2,269
+285
| +14% | +$33.9K | 0.1% | 148 |
|
|
2024
Q2 | $283K | Buy |
1,984
+47
| +2% | +$6.71K | 0.2% | 75 |
|
|
2024
Q1 | $249K | Sell |
1,937
-216
| -10% | -$27.7K | 0.21% | 78 |
|
|
2023
Q4 | $223K | Buy |
+2,153
| New | +$223K | 0.25% | 82 |
|